Price Move History
- Daily moves over 5%
- 0 115 sessions, January 20, 2026 to November 16, 2026
- Largest daily move
- +0.5% close of March 17, 2026
- 1-month change
- +0.9% closing prices, October 6, 2026 to November 16, 2026
Company Description
SC II Acquisition (NASDAQ: SCII) is classified in the shell companies industry within the Financial Services sector and carries a market capitalization of $255.5M.
SCII has gained 0.9% over the past month. The last closing price was $10.26.
This page collects what Stock Titan holds for SCII, including price data, SEC filings, and short interest trends.
Stock Performance
SC II Acquisition (SCII) closed at $10.26 on November 16, 2026. Over the past month, the price has gained 0.9%.
SCII Metrics & Rankings
Price returns through November 16, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
SEC Filings
SC II Acquisition has filed 10 recent SEC filings, including 3 Form 10-Q, 3 Form SCHEDULE 13G/A, 2 Form 8-K, 1 Form SCHEDULE 13G. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all SCII SEC filings →
Short Interest History
Short interest in SC II Acquisition (SCII) currently stands at 366 shares, up 11.6% from the previous reporting period, representing 0.0% of the float. Since January 2026, short interest has decreased by 98.5%.
Days to Cover History
Days to cover for SC II Acquisition (SCII) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume.
SCII Company Profile & Sector Positioning
SC II Acquisition (SCII) operates in the Shell Companies industry within the broader Financial Services sector and is listed on the NASDAQ.
Investors comparing SCII often look at related companies in the same sector, including Xterax Corporation II (XTER), Catalyst Acquisition Corp. (CATL), Drugs Made In America Acquisition Corp. (DMAA), Oaktree Acquisition Corp. III Life Sciences (OACC), and Newbury Street II Acquisition Corp (NTWO). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate SCII's relative position within its industry.